BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33854400)

  • 1. Machine Learning Can Predict Total Death After Radiofrequency Ablation in Liver Cancer Patients.
    Tong J; Liu P; Ji M; Wang Y; Xue Q; Yang JJ; Zhou CM
    Clin Med Insights Oncol; 2021; 15():11795549211000017. PubMed ID: 33854400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting postoperative liver cancer death outcomes with machine learning.
    Wang Y; Ji C; Wang Y; Ji M; Yang JJ; Zhou CM
    Curr Med Res Opin; 2021 Apr; 37(4):629-634. PubMed ID: 33539249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Peritoneal Metastasis of Gastric Cancer Patients Based on Machine Learning.
    Zhou C; Wang Y; Ji MH; Tong J; Yang JJ; Xia H
    Cancer Control; 2020; 27(1):1073274820968900. PubMed ID: 33115287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis on the value of soluble intercellular adhesion molecule-1 (sICAM-1), alpha fetoprotein (AFP), and aspartate aminotransferase/platelet ratio index (APRI) in predicting the prognostic survival of patients with primary liver cancer after radiofrequency ablation.
    Guo C; Liang H; Yuan W; Qin Y
    Ann Palliat Med; 2021 Apr; 10(4):4760-4767. PubMed ID: 33966425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supervised Machine Learning Predictive Analytics For Triple-Negative Breast Cancer Death Outcomes.
    Xu Y; Ju L; Tong J; Zhou C; Yang J
    Onco Targets Ther; 2019; 12():9059-9067. PubMed ID: 31802913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A machine learning-based predictor for the identification of the recurrence of patients with gastric cancer after operation.
    Zhou C; Hu J; Wang Y; Ji MH; Tong J; Yang JJ; Xia H
    Sci Rep; 2021 Jan; 11(1):1571. PubMed ID: 33452440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning to predict the cancer-specific mortality of patients with primary non-metastatic invasive breast cancer.
    Zhou CM; Xue Q; Wang Y; Tong J; Ji M; Yang JJ
    Surg Today; 2021 May; 51(5):756-763. PubMed ID: 33104877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of machine learning algorithms for predicting acute kidney injury after liver cancer resection.
    Lei L; Wang Y; Xue Q; Tong J; Zhou CM; Yang JJ
    PeerJ; 2020; 8():e8583. PubMed ID: 32140301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting postoperative delirium after microvascular decompression surgery with machine learning.
    Wang Y; Lei L; Ji M; Tong J; Zhou CM; Yang JJ
    J Clin Anesth; 2020 Nov; 66():109896. PubMed ID: 32504969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting postoperative gastric cancer prognosis based on inflammatory factors and machine learning technology.
    Zhou CM; Wang Y; Yang JJ; Zhu Y
    BMC Med Inform Decis Mak; 2023 Mar; 23(1):53. PubMed ID: 37004065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine Learning Algorithms for Predicting the Recurrence of Stage IV Colorectal Cancer After Tumor Resection.
    Xu Y; Ju L; Tong J; Zhou CM; Yang JJ
    Sci Rep; 2020 Feb; 10(1):2519. PubMed ID: 32054897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing Machine Learning Algorithms to Predict Pulmonary Complications After Emergency Gastrointestinal Surgery.
    Xue Q; Wen D; Ji MH; Tong J; Yang JJ; Zhou CM
    Front Med (Lausanne); 2021; 8():655686. PubMed ID: 34409047
    [No Abstract]   [Full Text] [Related]  

  • 13. Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma.
    Takada H; Tsuchiya K; Yasui Y; Nakakuki N; Tamaki N; Suzuki S; Nakanishi H; Itakura J; Takahashi Y; Kurosaki M; Asahina Y; Enomoto N; Izumi N
    Cancer Med; 2016 Nov; 5(11):3111-3120. PubMed ID: 27748052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy.
    Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Huo TI; Huang YH; Wu WC; Lin HC; Lee SD; Wu JC
    J Clin Gastroenterol; 2012 Jan; 46(1):62-70. PubMed ID: 21934530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy.
    Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Wu JC; Huo TI; Huang YH; Wu WC; Lin HC; Lee SD
    Clin Radiol; 2012 May; 67(5):429-36. PubMed ID: 22153231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Efficacy and Therapeutic Outcome of Bipolar Radiofrequency Ablation for the Treatment for Hepatocellular Carcinoma in the Real-World Setting, Compared with Monopolar Radiofrequency Ablation Conducted during the Same Period.
    Tanaka T; Takata K; Kunimoto H; Fukuda H; Yamauchi R; Tsuchiya N; Inomata S; Yokoyama K; Morihara D; Takeyama Y; Shakado S; Sakisaka S; Hirai F
    Oncology; 2020; 98(12):859-868. PubMed ID: 32799203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound.
    Zhang W; Luo E; Gan J; Song X; Bao Z; Zhang H; Chen M
    World J Surg Oncol; 2017 Jul; 15(1):122. PubMed ID: 28679433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.
    Doyle A; Gorgen A; Muaddi H; Aravinthan AD; Issachar A; Mironov O; Zhang W; Kachura J; Beecroft R; Cleary SP; Ghanekar A; Greig PD; McGilvray ID; Selzner M; Cattral MS; Grant DR; Lilly LB; Selzner N; Renner EL; Sherman M; Sapisochin G
    J Hepatol; 2019 May; 70(5):866-873. PubMed ID: 30615906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.
    Seo JY; Kim W; Kwon JH; Jin EH; Yu SJ; Kim HY; Jung YJ; Kim D; Kim YJ; Yoon JH; Lee HS
    Liver Int; 2013 Jul; 33(6):884-93. PubMed ID: 23461618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of risk factors and construction of predictive nomogram for early recurrence after radiofrequency ablation of hepatocellular carcinoma].
    Han RC; Ma XH; Wang S; Yang Y; Feng B; Liang M; Zhao XM
    Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):546-552. PubMed ID: 34034474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.